Asia Pacific Blood Glucose Test Strip Packaging Marketโ Forecast to 2032
ID: MRFR/MED/0183-HCR | 60 Pages | Author: Rahul Gotadki| November 2024
November 2023: Diabetes Awareness Month begins in November, and in conjunction with the occasion, Dario, an American digital health startup, has introduced a new smart blood sugar meter designed for users of the Apple iPhone 15. The immediate availability of real-time glucose monitoring will be extended to users of Dario's health management applications upon the introduction of the iPhone 15 and its new type-C USB connector. The pocket-sized device now functions with both Apple and Android users. It consists of a lancing device, a disposable test strip cartridge, and a glucose meter.
February 2023: Zoetis announced the distribution of the AlphaTrak 3 blood glucose monitoring device for diabetic canines and felines within the United States. For improved diabetic pet care, this updated version of the AlphaTrak includes a mobile application that facilitates and simplifies real-time communication and exchange of glucose levels and additional information with the veterinarian office. The precise data supplied by the state-of-the-art AlphaTrak 3 blood glucose monitoring device has enabled veterinarians to more effectively prescribe suitable medical interventions.
March 2023: TruDiagnostic, a healthcare data provider, has formed a partnership with NADMED, a Finnish provider of nicotinamide adenine dinucleotide (NAD) diagnostics, to offer patients in the United States a novel NAD+ blood diagnostic test. Said to be the only NAD+ testing instrument CE-approved, the Q-NADMED Blood instrument measures NAD+ and NADH from a minuscule blood sample. By employing standards utilized in the synthesis and storage of NAD, NADMED testing instruments are designed to facilitate the detection of metabolites in a sample in an exact and quantitative manner.
Report Attribute/Metric | Details |
Market Size 2032 | USD 1.21 Billion |
Compound Annual Growth Rate (CAGR) | 8.10% (2024-2032) |
Base Year | 2022 |
Market Forecast Period | 2024-2032 |
Historical Data | 2018- 2022 |
Market Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Type, End-use, and Region |
Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled | Roche Diagnostics, Abbott Laboratories, Lifescan, Inc., I-Sens, Inc., Trividia Health, Apex Biotechnology Corporation, Agamatrix Inc, Taidoc Technology Corporation, Universal Biosensors, Beijing Yicheng Electronic Co., Ltd., Sannuo Biosensor Inc., Shanghai Microsense Tm Inc., Acon Laboratories, Inc., Allmedicus |
Key Market Opportunities | Key market opportunities for the Blood Glucose Test Strip Packaging Market include the rising prevalence of diabetes globally and the increasing demand for portable and user-friendly glucose monitoring devices. |
Key Market Dynamics | The Blood Glucose Test Strip Packaging Market is driven by increasing diabetes prevalence and advancements in packaging technology that enhance product shelf life and user convenience. Regulatory standards and cost constraints also significantly impact market dynamics. |
Frequently Asked Questions (FAQ) :
ยฉ 2024 Market Research Future ยฎ (Part of WantStats Reasearch And Media Pvt. Ltd.)